DENTSPLY SIRONA Inc. Amends 8-K Filing

Ticker: XRAY · Form: 8-K/A · Filed: 2025-11-07T00:00:00.000Z

Sentiment: neutral

Topics: amendment, executive-changes, officer-appointment, financial-statements

TL;DR

DENTSPLY SIRONA filed an amendment to its 8-K, updating info on exec changes and compensation.

AI Summary

DENTSPLY SIRONA Inc. filed an amendment (8-K/A) on November 7, 2025, to its current report originally filed on October 31, 2025. This amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes financial statements and exhibits.

Why It Matters

This amendment provides updated information regarding changes in the company's leadership and executive compensation, which can impact investor confidence and strategic direction.

Risk Assessment

Risk Level: medium — Amendments to 8-K filings, especially those concerning executive changes and compensation, can signal internal shifts or potential governance issues that may affect the company's stability and future performance.

Key Players & Entities

FAQ

What specific items are being amended in the 8-K filing?

The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.

What was the original report date for the 8-K filing?

The original report date was October 31, 2025.

When was the amendment filed?

The amendment was filed on November 7, 2025.

What is the principal executive office address for DENTSPLY SIRONA Inc.?

The principal executive office is located at 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607.

What is the SIC code for DENTSPLY SIRONA Inc.?

The Standard Industrial Classification (SIC) code is 3843 for Dental Equipment & Supplies.

From the Filing

0000818479-25-000267.txt : 20251107 0000818479-25-000267.hdr.sgml : 20251107 20251107161322 ACCESSION NUMBER: 0000818479-25-000267 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 23 CONFORMED PERIOD OF REPORT: 20251031 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251107 DATE AS OF CHANGE: 20251107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 251462795 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K/A 1 xray-20251031.htm 8-K/A xray-20251031 0000818479 false 0000818479 2025-10-31 2025-10-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 31, 2025 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North Carolina 28277-3607 (Address of principal executive offices) (Zip Code) ( 844 ) 848-0137 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share XRAY The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On November 6, 2025, DENTSPLY SIRONA Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) reporting that the Company had determined that Matthew E. Garth will no longer serve as the Executive Vice President and Chief Financial Officer of the Company effective November 5, 2025 (the “Separation Date”). This Amendment No. 1 on Form 8-K/A amends the Original

View on Read The Filing